1260106-23-7 Usage
Molecular structure
1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-ene-1-carboxylic acid ethyl ester consists of a cyclohexene ring with a boron-containing substituent, an ester group, and a methyl group.
Functional groups
The compound contains a carboxylic acid group, an ethyl ester group, and a boronic acid functional group.
Reagent use
It is commonly used in organic synthesis as a reagent for the introduction of boronic acid functional groups.
Role in Suzuki-Miyaura cross-coupling reactions
The compound is often utilized in Suzuki-Miyaura cross-coupling reactions, which are widely used in the pharmaceutical and agrochemical industries.
Applications in industries
It is used in the synthesis of biaryl compounds, which are important for the development of new drugs and materials in the pharmaceutical and agrochemical industries.
Facilitation of carbon-carbon bond formation
The compound aids in the formation of carbon-carbon bonds, making it a valuable reagent in organic synthesis.
Intermediate in organic compound production
1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-ene-1-carboxylic acid ethyl ester serves as a valuable intermediate in the production of various organic compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 1260106-23-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,6,0,1,0 and 6 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1260106-23:
(9*1)+(8*2)+(7*6)+(6*0)+(5*1)+(4*0)+(3*6)+(2*2)+(1*3)=97
97 % 10 = 7
So 1260106-23-7 is a valid CAS Registry Number.
1260106-23-7Relevant articles and documents
MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE
-
Paragraph 00635; 00636, (2019/03/05)
The present disclosure provides for compounds of Formula (I) wherein A2, A3, A4, A6, A7, A8, A15, RA, R5, R9, R10A, R10B, R11, R12, R13, R14, R16, W, X, and Y have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including cancer. Also provided are pharmaceutical compositions comprising compounds of Formula (I).
As a substituted bicyclic pyrazole compound and use ROR γ T inhibitor
-
, (2019/01/10)
The present invention relates to compounds according to Formula I: and pharmaceutically acceptable salts thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or conditions.
3-CYCLOHEXENYL AND CYCLOHEXYL SUBSTITUTED INDOLE AND INDAZOLE COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
-
, (2015/07/15)
The present invention relates to compounds according to Formula I and pharmaceutically acceptable salts or solvates thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or conditions.
